mortality/aging
• unlike mice that do not carry Casp8tm1.1Yuan, compound heterozygous mutants survive after injection with an anti-Fas Ab
|
homeostasis/metabolism
• unlike mice that do not carry Casp8tm1.1Yuan, compound heterozygous mutants survive and do not display liver damage after injection with an anti-Fas Ab
|